Why Corporate Travel Management, Kingsgate, Liontown, and Neuren shares are racing higher

These ASX shares are ending the week on a positive note.

| More on:
a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The S&P/ASX 200 Index (ASX: XJO) is on course to end the week with a small gain. In afternoon trade, the benchmark index is up 0.2% to 6,978.3 points.

Four ASX shares that are climbing more than most today are listed below. Here's why they are rising:

Corporate Travel Management Ltd (ASX: CTD)

The Corporate Travel Management share price is up almost 4% to $17.37. This may have been driven by a broker note out of Morgan Stanley. It has retained its overweight rating and $28.00 price target. The broker feels the market is being too negative and believes the company can achieve its guidance in FY 2023.

Kingsgate Consolidated Limited (ASX: KCN)

The Kingsgate share price has jumped 17% to $1.77. Investors have been buying this gold miner's shares after it announced the official reopening of its Chatree mine in Thailand. This follows the granting of approval from the Department of Primary Industries and Mines. Management described it as "a truly remarkable moment."

Liontown Resources Ltd (ASX: LTR)

The Liontown share price is up 4% to $1.59. This is despite there being no news out of the lithium developer. However, it is worth noting that a number of lithium shares are climbing today. Some investors may believe a buying opportunity has opened up following heavy declines in recent sessions.

Neuren Pharmaceuticals Ltd (ASX: NEU)

The Neuren Pharmaceuticals share price is up a further 8% to $13.40. This biotech company's shares have been on fire this week thanks to news that its treatment for Rett's Syndrome has been granted US FDA approval. This is the first and only approved treatment for the rare genetic neurological and developmental disorder that affects the way the brain develops. It is expected to be available by the end of April 2023.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Corporate Travel Management. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Man drawing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why Latin Resources, Newmont, Nick Scali, and ResMed shares are surging today

These ASX shares are ending the week strongly. But why?

Read more »

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

Let's also take a look at what the various ASX sectors were doing this Wednesday.

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Argosy Minerals, Immutep, Pointsbet, and Regis Resources shares are racing higher

These shares are having a strong session on Wednesday. But why?

Read more »

Businessman smiles with arms outstretched after receiving good news.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another strong showing from the share market today.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Healthco Healthcare, Medadvisor, Ramsay Health Care, and Tamboran shares are rising

These shares are having a strong session. But why?

Read more »

drug capsule opening up to reveal dollar signs signifying rising asx share price
Share Gainers

If you invested $6,000 in Mesoblast shares a month ago you'd have $15,636 now!

Mesoblast shares have been on a tear this past month. But why?

Read more »

Smiling man working on his laptop.
Share Gainers

Here are the top 10 ASX 200 shares today

It was back to the races for ASX shares today, in a confident start to the week.

Read more »

rising gold share price represented by a green arrow on piles of gold block
Share Gainers

Here are the top 10 ASX 200 shares today

It was a horrible way to end the trading week today for ASX investors.

Read more »